Sangui Biotech International (HAM:SBH) Short-Term Capital Lease Obligation : €0.02 Mil (As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Sangui Biotech International Short-Term Capital Lease Obligation?

Sangui Biotech International's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2023 was €0.02 Mil.

Sangui Biotech International's quarterly Short-Term Capital Lease Obligation stayed the same from Sep. 2022 (€0.02 Mil) to Dec. 2022 (€0.02 Mil) but then increased from Dec. 2022 (€0.02 Mil) to Mar. 2023 (€0.02 Mil).

Sangui Biotech International's annual Short-Term Capital Lease Obligation stayed the same from Jun. 2020 (€0.01 Mil) to Jun. 2021 (€0.01 Mil) but then increased from Jun. 2021 (€0.01 Mil) to Jun. 2022 (€0.02 Mil).

Sangui Biotech International Short-Term Capital Lease Obligation Historical Data

The historical data trend for Sangui Biotech International's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Short-Term Capital Lease Obligation Chart

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.01

0.02

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.02

Sangui Biotech International Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Sangui Biotech International Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (HAM:SBH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (HAM:SBH) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SGBI:USA

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.